Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    August 2024
  1. SHEN N, Ramanathan S, Horns JJ, Hyngstrom JR, et al
    The benefit of sentinel lymph node biopsy in elderly patients with melanoma: A retrospective analysis of SEER Medicare data (2010-2018).
    Am J Surg. 2024;237:115896.
    PubMed     Abstract available


    June 2024
  2. HAYKAL T, Contreras C
    Adjuvant PD-1-based therapies for high-risk resected melanomas are here to stay.
    Am J Surg. 2024 Jun 1:115791. doi: 10.1016/j.amjsurg.2024.115791.
    PubMed    


    February 2024
  3. VALENZUELA CD, Fowler G, Kozuma K, Kusaka S, et al
    Long-term outcomes after amputation and sentinel node biopsy for subungual melanoma: A single-institution series.
    Am J Surg. 2024 Feb 24:S0002-9610(24)00138-7. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available


  4. DOWNEY J, Hamm J, Baliski C
    Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
    Am J Surg. 2024 Feb 2:S0002-9610(24)00029-1. doi: 10.1016/j.amjsurg.2024.
    PubMed     Abstract available


    October 2023
  5. WILSON AK, Lourdault K, Ostad T, Stern S, et al
    Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?
    Am J Surg. 2023 Oct 17:S0002-9610(23)00564-0. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


    September 2023
  6. HANUSCHAK D, DePiero M, DeMoraes M, Bailly S, et al
    The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer.
    Am J Surg. 2023 Sep 29:S0002-9610(23)00496-8. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  7. ISTL AC
    Skin in the Game: Surgical delays in our patients with melanoma.
    Am J Surg. 2023 Sep 15:S0002-9610(23)00473-7. doi: 10.1016/j.amjsurg.2023.
    PubMed    


    May 2023
  8. SCHWANTES IR, Sutton T, Behrens S, Fowler G, et al
    Metastasectomy for metastatic melanoma in the era of effective systemic therapy.
    Am J Surg. 2023 May 23:S0002-9610(23)00184-8. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


    April 2023
  9. HEWITT DB, Beane JD, Grignol VP, Contreras CM, et al
    Association between surgical delay and outcomes among patients with invasive cutaneous melanoma.
    Am J Surg. 2023 Apr 29:S0002-9610(23)00183-6. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


    October 2022
  10. KHAN M, Thompson J, Kiiskila L, Oboh O, et al
    Timing and necessity of staging imaging in clinical stage II cutaneous melanoma: Cost-effectiveness and clinical decision analysis.
    Am J Surg. 2022 Oct 17:S0002-9610(22)00652-3. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


    September 2022
  11. MOTT NM, Duncan ZN, Pesavento CM, Vastardis AF, et al
    Implementation of melanoma guidelines in the multidisciplinary setting: A qualitative analysis.
    Am J Surg. 2022 Sep 25. pii: S0002-9610(22)00588.
    PubMed     Abstract available


    November 2021
  12. WONG DL, Glazer ES, Tsao M, Deneve JL, et al
    Impact of adjuvant therapies following surgery for anal melanoma.
    Am J Surg. 2021 Nov 11. pii: S0002-9610(21)00657.
    PubMed     Abstract available


    March 2021
  13. ARNOT SP, Han G, Fortino J, Han D, et al
    Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy.
    Am J Surg. 2021 Mar 17. pii: S0002-9610(21)00163.
    PubMed     Abstract available


    December 2020
  14. CARTER TM, Strassle PD, Ollila DW, Stitzenberg KB, et al
    Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients?
    Am J Surg. 2020 Dec 25. pii: S0002-9610(20)30818.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.